EXHIBIT 23.1


            Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated March 10, 2006, in the Registration Statement (Form
S-1) and related prospectus of ImaRx Therapeutics, Inc. for the registration of
shares of its common stock.


                                                /s/ Ernst & Young LLP

Phoenix, Arizona
May 16, 2006